Lv739
5000 积分 2023-09-04 加入
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study
1个月前
已完结
Bioinspired ruthenium-manganese-oxygen complex for biocatalytic and radiosensitization therapies to eradicate primary and metastatic tumors
1个月前
已完结
Squamous Non-Small Cell Lung Cancer: Current and Emerging Treatment Options
3个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
4个月前
已完结
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
4个月前
已完结
A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)
4个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
4个月前
已完结
Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy
4个月前
已完结
Reframing the paradigm: stereotactic body radiation therapy as an engineer of the tumor immune microenvironment
4个月前
已完结
Combination treatment of HCC with SBRT and immune checkpoint inhibition
4个月前
已完结
皖公网安备34019202002308
